PETER S GARCIA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER S GARCIA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER S GARCIA. PETER S GARCIA is Vice President, CFO in PDL BIOPHARMA, INC. ($PDLI) and Senior V.P. and C.F.O. in ARCA biopharma, Inc. ($ABIO) and Chief Financial Officer in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Latest Insider Trading Transactions of PETER S GARCIA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXO, ABIO, PDLI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 19.00 | 88,137 | 1,674,603 | 88,137 | |
Apr 01 2019 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 3.72 | 628,930 | 2,339,620 | 628,930 | |
Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Sell | D | 0.00 | 226,442 | 0 | 225,029 | 451.5 K to 225 K (-50.16 %) |
Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Payment of Exercise | F | 3.02 | 3,553 | 10,730 | 451,471 | 455 K to 451.5 K (-0.78 %) |
Sep 27 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 2.52 | 339,678 | 855,989 | 339,678 | |
Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 2.94 | 694,900 | 2,043,006 | 694,900 | |
Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Sell | D | 0.00 | 17,818 | 0 | 455,024 | 472.8 K to 455 K (-3.77 %) |
Mar 27 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 1.98 | 5,000 | 9,890 | 472,842 | 467.8 K to 472.8 K (+1.07 %) |
Mar 27 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 1.98 | 5,000 | 9,884 | 467,842 | 462.8 K to 467.8 K (+1.08 %) |
Mar 27 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 1.98 | 10,000 | 19,757 | 462,842 | 452.8 K to 462.8 K (+2.21 %) |
Mar 27 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 1.98 | 350 | 691 | 452,842 | 452.5 K to 452.8 K (+0.08 %) |
Mar 27 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 1.97 | 4,650 | 9,179 | 452,492 | 447.8 K to 452.5 K (+1.04 %) |
Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Grant | A | 2.04 | 212,669 | 433,845 | 447,842 | 235.2 K to 447.8 K (+90.43 %) |
Dec 15 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Sell | D | 0.00 | 1,919 | 0 | 235,173 | 237.1 K to 235.2 K (-0.81 %) |
Aug 10 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 3.00 | 5,000 | 14,980 | 237,092 | 232.1 K to 237.1 K (+2.15 %) |
Aug 10 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 3.00 | 5,000 | 14,980 | 237,092 | 232.1 K to 237.1 K (+2.15 %) |
Aug 10 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 2.99 | 5,000 | 14,970 | 232,092 | 227.1 K to 232.1 K (+2.20 %) |
Aug 10 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 2.99 | 5,000 | 14,970 | 232,092 | 227.1 K to 232.1 K (+2.20 %) |
Jan 28 2016 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Grant | A | 3.22 | 101,051 | 325,384 | 227,092 | 126 K to 227.1 K (+80.17 %) |
Dec 16 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 3.64 | 5,000 | 18,200 | 126,041 | 121 K to 126 K (+4.13 %) |
Dec 16 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 3.42 | 10,000 | 34,245 | 121,041 | 111 K to 121 K (+9.01 %) |
Oct 05 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Grant | A | 4.95 | 15,169 | 75,087 | 111,041 | 95.9 K to 111 K (+15.82 %) |
Aug 17 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 5.80 | 300 | 1,740 | 95,872 | 95.6 K to 95.9 K (+0.31 %) |
Aug 17 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 5.79 | 7,300 | 42,267 | 95,572 | 88.3 K to 95.6 K (+8.27 %) |
Aug 17 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 5.79 | 2,400 | 13,896 | 88,272 | 85.9 K to 88.3 K (+2.79 %) |
Aug 17 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 5.86 | 2,200 | 12,892 | 85,872 | 83.7 K to 85.9 K (+2.63 %) |
Aug 17 2015 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Buy | P | 5.86 | 7,800 | 45,707 | 83,672 | 75.9 K to 83.7 K (+10.28 %) |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 12,644 | 128,716 | 12,644 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 37,356 | 380,284 | 37,356 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 110,000 | 1,119,800 | 110,000 |
Page: 1